Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen
This article is from
The Cancer Letter
archive.
Vol. 37 No. 4 | April 25, 2014
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
Page 2: The Debate Over Brigham’s Containment Bag Study
November 21, 2014
TCL Archive
NIH Updates Policy On Large Grants
May 10, 1996
TCL Archive
UICC Fellowship Program Announced
January 2, 1981
TCL Archive
Childhood cancer Death Rates Decline, Incidence Stable, NCI Says In Report
July 30, 1999
TCL Archive
CCOP Reviewers Briefed On Program Objective, Criteria
January 7, 1983
TCL Archive
Combination Radiation/Vaccine May Benefit Some Patients
April 29, 2005